DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "World Vitreous Tamponades Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.
Vitreous Tamponades are postoperative tools used in retinal detachment vitrectomy procedures. Retinal detachment is very serious medical complication and if not treated on time, can lead to permanent loss of vision. In the United States about 6% of population is estimated to suffer from retinal breaks, with annual incidences of 1 in 10,000. Vitrectomy is a surgical technique used in the correction of retinal detachment, which involves the removal of small amounts of vitreous gel from the human eye. At the end of vitrectomy, tamponades are injected into the eye to hold the retina in place and help in healing process.
There is unmet market need for safe and technologically superior devices. The current viterectomy procedures are complicated and associated with adverse events such as cataract, glaucoma and recurrence of retinal detachment; making viterectomy a less invasive and a considerably successful procedure, would be a key challenge for market players. The key factors driving the vitreous tamponades market are; rising incidences of ophthalmic diseases, higher prevalence of diabetes and a global rise in the count of geriatric population, as old age and diabetes patients are at a higher risk of developing retinal diseases. However, the high cost of treatment, lack of expertise, a stringent regulatory requirement and an ambiguous reimbursement scenario are likely to restrict the market growth.
Scope of the Report:
Vitreous Tamponades Market - By Type
- Gaseous Tamponades
- Sulphur Hexafluoride (SF6)
- Hexafluoroethane (C2F6)
- Octafluoropropane (C3F8)
- Liquid Tamponades
- Silicone Oil
Vitreous Tamponades Market - By Geography
- North America
For more information about this report visit http://www.researchandmarkets.com/research/swhg2q/world_vitreous